期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Site-specific PEGylation of lidamycin and its antitumor activity 被引量:2
1
作者 Liang Li Boyang Shang +2 位作者 Lei Hu Rongguang Shao Yongsu Zhen 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2015年第3期264-269,共6页
In this study,N-terminal site-specific mono-PEGylation of the recombinant lidamycin apoprotein(r LDP) of lidamycin(LDM) was prepared using a polyethyleneglycol(PEG) derivative(Mw20 k Da) through a reactive terminal al... In this study,N-terminal site-specific mono-PEGylation of the recombinant lidamycin apoprotein(r LDP) of lidamycin(LDM) was prepared using a polyethyleneglycol(PEG) derivative(Mw20 k Da) through a reactive terminal aldehyde group under weak acidic conditions(p H 5.5).The biochemical properties of m PEG-r LDP-AE,an enediyne-integrated conjugate,were analyzed by SDSPAGE,RP-HPLC,SEC-HPLC and MALDI-TOF.Meanwhile,in vitro and in vivo antitumor activity of m PEG-r LDP-AE was evaluated by MTT assays and in xenograft model.The results indicated that m PEGr LDP-AE showed significant antitumor activity both in vitro and in vivo.After PEGylation,m PEG-r LDP still retained the binding capability to the enediyne AE and presented the physicochemical characteristics similar to that of native LDP.It is of interest that the PEGylation did not diminish the antitumor efficacy of LDM,implying the possibility that this derivative may function as a payload to deliver novel tumortargeted drugs. 展开更多
关键词 enediyne antibiotic Polyethylene glycol Site-specific PEGylation LIDAMYCIN
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部